Q-omics provides the consensus-scored IGLVI-38 profile across patient tissues and cancer cell-line models. IGLVI-38 expression is associated with patient survival in 11 of 34 cancer types, with the highest sampling consensus in MESO. Additionally, IGLVI-38 RNA expression shows 5,806 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight MESO, and STAD as cancer lineages where IGLVI-38 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for IGLVI-38 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes IGLVI-38 survival associations across molecular data types. IGLVI-38 RNA expression shows survival associations in the most cancer types (11). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

IGLVI-38 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	11	MESO (72)	view →

This table ranks reproducible IGLVI-38 RNA expression–survival associations across cancer types. High IGLVI-38 expression shows unfavorable associations in MESO, TGCT, KIRP, HNSC and THCA, but favorable associations in UCEC. The MESO Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify MESO as the clearest survival context for IGLVI-38 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.052	0.567	<.001	72	view →
TGCT	OS	Tertile	II,III,IV	0.501	0.996	<.001	66	view →
UCEC	DFS	Tertile	III,IV	1.000	0.772	.011	36	view →
KIRP	OS	Tertile	III,IV	0.111	0.697	<.001	36	view →
HNSC	OS	Tertile	IV	0.192	0.649	.012	30	view →
THCA	OS	Tertile	II,III,IV	0.782	0.967	<.001	27	view →

Pink = unfavorable, green = favorable. all 11 lineages →

IGLVI-38-MESO (OS)

Kaplan–Meier survival curve for IGLVI-38 RNA expression in MESO: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with IGLVI-38 in patient tissues and cancer cell lines. In patient samples, IGLVI-38 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	5,806	STAD (5040)	view →
RNA	4,096	ESCA (1088)	view →